Press Releases

Mednow Advances National Expansion through Manitoba

  • Pharmacy license application filed for Winnipeg fulfillment center
  • With operations expected to begin in calendar Q3 2021, Winnipeg fulfillment center will allow Mednow to Service Manitoba and Saskatchewan

March 19, 2021 07:30 AM Eastern Daylight Time

VANCOUVER, British Columbia–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”)(TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce a significant operational milestone in advancing its national expansion strategy. Mednow has filed an application for a pharmacy license with the Manitoba College of Pharmacists through a wholly-owned subsidiary, Mednow Pharmacy MB Ltd. Upon successful application, this wholly-owned entity will be a licensed pharmacy that will be regulated by Manitoba College of Pharmacists as well as provincial and federal regulatory bodies with oversight of pharmacy practices.

In conjunction with this application, the Company has appointed Carey Lai as Director of Pharmacy Operations for Manitoba and Saskatchewan. Mr. Lai has over 15 years’ experience in pharmacy operations.

“We are rapidly advancing our national expansion strategy. Through our fulfillment centers in Ontario and British Columbia, we can service those two entire provinces and with same-day delivery in the Greater Vancouver and Greater Toronto areas. Once our Manitoba fulfillment center is up and running, we will be adding another two provinces to our distribution platform. National coverage is imperative to our long-term success and our goal of becoming a household name in Canadian healthcare. Furthermore, a national presence will open the business-to-business market whereby Mednow will be able to partner with employers and employee benefits providers to provide holistic healthcare solutions,” said Karim Nassar, CEO of Mednow.

About Mednow Inc.

Mednow is a healthcare technology company offering virtual access with exceptional care. Designed with access and quality care in mind, provides virtual pharmacy services with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experience. Pharmacy services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, as well as access to telemedicine.

To learn more, follow Mednow on FacebookTwitterLinkedIn and Instagram, as well as visit

On Behalf of the Board of Directors,

Karim Nassar

Karim Nassar
Chief Executive Officer

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the timing of operations beginning in Manitoba, receipt of all required regulatory approvals from the Manitoba College of Pharmacists and other regulatory bodies with oversight of pharmacy practices, the ability to service clients in Saskatchewan from the Manitoba fulfillment centre and the benefits of a national presence. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Company and the opinions and estimates of management of the Company as of the date of this press release, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Company. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of the Company, or at all, the risk that the Company will not receive required regulatory approvals and the other risks and uncertainties applicable to the Company and the business of the Company as set forth in the Company’s final long form prospectus dated February 26, 2021 and its other disclosure available under the Company’s profile at There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations. We seek safe harbor.


Investor Relations:
Marc Charbin

Kieran Lawler